The Patient experience healthcare company (Oneview Healthcare), the University of Oxford and Oxford University Hospitals NHS Foundation Trust signed a research and development agreement for clinical pathways, following the success of a Prostate Cancer Pathway pilot.
CHICAGO, IL, USA, December 27, 2017 — Oneview Healthcare PLC (“Oneview”) (ASX:ONE), have announced a partnership with The Chancellor Masters and Scholars of the University of Oxford (the “University”) and Oxford University Hospitals NHS Foundation Trust (“OUH”) to continue research and development on a clinical pathways product. The solution will ease administrative burden, digitise currently paper-based processes and ultimately expedite wait times and access to care.
In conjunction with a leading engineering company, The University, OUH and Oneview entered into a partnership in an agreement dated 31 January 2017 to pilot a digital pathways for prostate cancer to improve patient outcomes and deliver cost efficiencies to health systems. That pilot’s success is the catalyst for the new agreement. The prostate cancer pilot succeeded in the areas of clinical staff uptake, meeting or exceeding wait time goals, and providing an easy-to-use interface the clinicians embraced. The new research and development will focus on expanding the technology to include full commercial deployment at Oxford via a SMART on FHIR1 integration and expansion of scope to other types of cancer (beyond prostate cancer). The partners expect to commercialise the new products globally, helping healthcare organisations around the world to digitize care pathways, connecting information across systems to drive clinical transformation and reduce variation.”
James Fitter, CEO of Oneview Healthcare stated, “This has been a textbook case of agile development with our team working side-by-side with the Oxford clinicians to solve real-world problems. Combining Oxford’s clinical expertise with our software innovation and integration skills has proved a powerful combination. We are delighted with the results of the pilot and the opportunity to move forward in developing other life-changing cancer pathways. We take pride in our partnership with The University and OUH, and are honored that we can all work together to advance technology that has so much potential to changes lives around the world.”
Prof Freddie Hamdy (Head of Nuffield Department of Surgical Sciences, University of Oxford and Divisional director of Surgery and Oncology at OUH) commented “this is one of the most innovative projects Oxford have done in the past few years.”
About The University
The University is dedicated to advancing learning by teaching and research. The University conducts clinical research to improve healthcare via disease diagnosis, treatment and prevention.
OUH is a world-renowned centre of clinical excellence and one of the largest NHS teaching trusts in the UK.
Oneview provides interactive healthcare technologies for patients, families and caregivers. Oneview have offered an inpatient experience solution since 2009 and a mobile application for outpatient initiatives since 2016, all designed to create better experiences for patients, families, clinicians and hospital staff.
1 SMART on FHIR is an open standards-based platform for medical apps designed to promote interoperability